Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 48601-48650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04462458
M-ARS ACL Post-marketing Surveillance Study
N/ARecruiting
200 participants
Started: Jul 1, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor3 locations
NCT06063005
Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole
NARecruiting
76 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05411744
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
PHASE4Recruiting
25 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2029
4 conditions1 sponsor1 location
NCT05428137
Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals
NARecruiting
180 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05597709
Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
N/ARecruiting
2,900 participants
Started: Jul 1, 2022 · Completed: Jun 1, 2027
2 conditions12 sponsors1 location
NCT04565795
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
NARecruiting
87 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors4 locations
NCT05230758
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
PHASE3Recruiting
140 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor19 locations
NCT05663788
Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer
NARecruiting
166 participants
Started: Jul 1, 2022 · Completed: Mar 31, 2024
2 conditions4 sponsors12 locations
NCT05306145
Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
NARecruiting
118 participants
Started: Jun 30, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05399433
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis
NARecruiting
100 participants
Started: Jun 30, 2022 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05420779
A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations
PHASE2Recruiting
125 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05040178
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
N/ARecruiting
20 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2032
3 conditions2 sponsors5 locations
NCT05208879
CArotenoid in hypoChOlesterolemia
N/ARecruiting
40 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor3 locations
NCT05788614
Retroversion in Reverse Shoulder Arthroplasty
NARecruiting
90 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05437315
GD2/PSMA Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05483816
MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts
NARecruiting
40 participants
Started: Jun 30, 2022 · Completed: Feb 28, 2028
5 conditions2 sponsors1 location
NCT05437341
PSMA/CD70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05353322
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
NARecruiting
324 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2026
4 conditions2 sponsors1 location
NCT05736146
Validating Gulf War Illness Blood Biomarkers
N/ARecruiting
100 participants
Started: Jun 30, 2022 · Completed: Mar 1, 2026
2 conditions4 sponsors3 locations
NCT05513755
Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)
NARecruiting
92 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
1 condition18 sponsors1 location
NCT04991116
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
PHASE3Recruiting
650 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2029
1 condition1 sponsor97 locations
NCT05350332
Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy
NARecruiting
200 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05037305
VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey
NARecruiting
500 participants
Started: Jun 30, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor2 locations
NCT04042844
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
PHASE2Recruiting
99 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor19 locations
NCT05076682
Reverse Triple Negative Immune Resistant Breast Cancer
PHASE2Recruiting
70 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06088576
Using a Digital Application for Adolescents in Dropout of Care in Mental Health : Facilitate the Return in Classic Care With Telepsychiatry, Tchats, Forums and a Home Medical Team.
NARecruiting
50 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05418088
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
PHASE1Recruiting
54 participants
Started: Jun 30, 2022 · Completed: Jul 31, 2026
18 conditions2 sponsors2 locations
NCT05244551
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
PHASE1Recruiting
85 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor22 locations
NCT05437328
GD2/CD56 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05576818
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
PHASE3Recruiting
66 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05338619
A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
PHASE2Recruiting
77 participants
Started: Jun 30, 2022 · Completed: Mar 2, 2026
3 conditions2 sponsors13 locations
NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
PHASE3Recruiting
220 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor47 locations
NCT04990713
QoR40 Between Intercostal Block and Intercostal Block and Serratus Plane Catheter During VATS
NARecruiting
200 participants
Started: Jun 30, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT04648280
Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2028
1 condition5 sponsors10 locations
NCT05309993
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
NARecruiting
130 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT05436496
CD19/70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05438368
GD2/CD70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05163288
A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C
PHASE3Recruiting
53 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor14 locations
NCT05364827
CT Coronary Angiography Prior to CTO PCI
NARecruiting
20 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05432882
CD19/22 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05436509
CD19/79b Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05223894
Treating Heart Failure With hiPSC-CMs
PHASE1/PHASE2Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05726526
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
NARecruiting
340 participants
Started: Jun 30, 2022 · Completed: Mar 30, 2026
2 conditions1 sponsor5 locations
NCT05206838
Achilles Tendon for the Treatment of Gluteus Medius Insufficiency
NARecruiting
44 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2028
4 conditions4 sponsors1 location
NCT05141682
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
PHASE1/PHASE2Recruiting
27 participants
Started: Jun 29, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors2 locations
NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
PHASE3Recruiting
168 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2022
2 conditions2 sponsors9 locations
NCT05566275
Remote Cognitive Assessment for Surgical Patients
N/ARecruiting
30 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2023
2 conditions2 sponsors1 location
NCT04814446
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
PHASE3Recruiting
146 participants
Started: Jun 29, 2022 · Completed: Jun 29, 2026
1 condition1 sponsor1 location
NCT05218850
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
PHASE1Recruiting
10 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06156891
PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
PHASE2Recruiting
60 participants
Started: Jun 29, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor1 location